HuGE Literature Finder
Records
1
-
28
| Association of polymorphisms in promoter region of TNF-? -238 and -308 with clinical outcomes in patients with immune-mediated inflammatory diseases on anti-TNF therapy. Rheumatology international 2021 Oct . Miler Marijana, Nikolac Gabaj Nora, ?elap Ivana, Grazio Simeon, Tomaši? Vedran, Biš?anin Alen, Mitrovi? Joško, ?erek Lovorka, Morovi?-Vergles Jadranka, Vrki? Nada, Štefanovi? Mar |
| Exploring pharmacogenetic variants for predicting response to anti-TNF therapy in autoimmune diseases: a meta-analysis. Pharmacogenomics 2021 4 22 (7): 435-445. Antonatos Charalabos, Stavrou Eleana F, Evangelou Evangelos, Vasilopoulos Yiann |
| Genetic variants involved in innate immunity modulate the risk of inflammatory bowel diseases in an understudied Malaysian population. Journal of gastroenterology and hepatology 2021 12 37 (2): 342-351. Luu Laurence Don Wai, Popple Georgia, Tsang Samuel Pok Wei, Vinasco Karla, Hilmi Ida, Ng Ruey Terng, Chew Kee Seang, Wong Shin Yee, Riordan Stephen, Lee Way Seah, Mitchell Hazel M, Kaakoush Nadeem O, Castaño-Rodríguez Natal |
| Patients With Low Drug Levels or Antibodies to a Prior Anti-Tumor Necrosis Factor Are More Likely to Develop Antibodies to a Subsequent Anti-Tumor Necrosis Factor. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2021 1 20 (2): 465-467.e2. Vande Casteele Niels, Abreu Maria T, Flier Sarah, Papamichael Konstantinos, Rieder Florian, Silverberg Mark S, Khanna Reena, Okada Lauren, Yang Lei, Jain Anjali, Cheifetz Adam |
| Recent Developments in HLA B27 Anterior Uveitis. Frontiers in immunology 2021 1 11 608134. Wakefield Denis, Clarke Daniel, McCluskey Pet |
| Vitamin D-Related Genetics as Predictive Biomarker of Clinical Remission in Adalimumab-Treated Patients Affected by Crohn's Disease: A Pilot Study. Pharmaceuticals (Basel, Switzerland) 2021 12 14 (12): . Cusato Jessica, Bertani Lorenzo, Antonucci Miriam, Tomasello Cristina, Caviglia Gian Paolo, Dibitetto Simone, Massano Alessandro, Mangia Michela, Mula Jacopo, Ceccarelli Linda, Costa Francesco, Zanzi Federico, Astegiano Marco, Ribaldone Davide Giuseppe, D'Avolio Anton |
| IL6 genetic variants haplotype is associated with susceptibility and disease activity but not with therapy response in patients with inflammatory bowel disease. International journal of colorectal disease 2020 Oct . Gonçalves Beatriz Piantoni, Flauzino Tamires, Inoue Cláudia Junko, de Paula Jaqueline Costa Castardo, Galvão Talita Cristina, de Alcantara Camila Cataldi, Miyazaki Paula Kikuchi, Rosa Lucilene, Westmore Silva, Lozovoy Marcell Alysson Batisti, Reiche Edna Maria Vissoci, Simão Andréa Name Cola |
| Paradoxical Psoriasis Induced by Anti-TNF? Treatment: Evaluation of Disease-Specific Clinical and Genetic Markers. International journal of molecular sciences 2020 10 21 (21): . Bucalo Agostino, Rega Federica, Zangrilli Arianna, Silvestri Valentina, Valentini Virginia, Scafetta Giorgia, Marraffa Federica, Grassi Sara, Rogante Elena, Piccolo Arianna, Cucchiara Salvatore, Viola Franca, Bianchi Luca, Ottini Laura, Richetta Anton |
| Influence of Crohn's disease related polymorphisms in innate immune function on ileal microbiome. PloS one 2019 3 14 (2): e0213108. Li Ellen, Zhang Yuanhao, Tian Xinyu, Wang Xuefeng, Gathungu Grace, Wolber Ashley, Shiekh Shehzad S, Sartor R Balfour, Davidson Nicholas O, Ciorba Matthew A, Zhu Wei, Nelson Leah M, Robertson Charles E, Frank Daniel |
| Microbial network disturbances in relapsing refractory Crohn's disease. Nature medicine 2019 1 25 (2): 323-336. Yilmaz Bahtiyar, Juillerat Pascal, Øyås Ove, Ramon Charlotte, Bravo Francisco Damian, Franc Yannick, Fournier Nicolas, Michetti Pierre, Mueller Christoph, Geuking Markus, Pittet Valerie E H, Maillard Michel H, Rogler Gerhard, , Wiest Reiner, Stelling Jörg, Macpherson Andrew |
| A FCGR3A Polymorphism Predicts Anti-drug Antibodies in Chronic Inflammatory Bowel Disease Patients Treated With Anti-TNF. International journal of medical sciences 2018 15 (1): 10-15. Romero-Cara Patricia, Torres-Moreno Daniel, Pedregosa José, Vílchez Juan Antonio, García-Simón María Sergia, Ruiz-Merino Guadalupe, Morán-Sanchez Senador, Conesa-Zamora Pab |
| Evaluation of tumor necrosis factor (TNF)-a mRNA expression level and the rs1799964 polymorphism of the TNF-a gene in peripheral mononuclear cells of patients with inflammatory bowel diseases. Biomedical reports 2017 Jun 6 (6): 698-702. Nourian Mahyar, Chaleshi Vahid, Pishkar Leila, Azimzadeh Pedram, Baradaran Ghavami Shaghayegh, Balaii Hedieh, Alinaghi Samaneh, Shahrokh Shabnam, Asadzadeh Aghdaei Hamid, Zali Mohammad Re |
| Genetically determined high activity of IL-12 and IL-18 in ulcerative colitis and TLR5 in Crohns disease were associated with non-response to anti-TNF therapy. The pharmacogenomics journal 2017 Jan . Bank S, Andersen P S, Burisch J, Pedersen N, Roug S, Galsgaard J, Turino S Y, Brodersen J B, Rashid S, Rasmussen B K, Avlund S, Olesen T B, Hoffmann H J, Nexø B A, Sode J, Vogel U, Andersen |
| Alterations in the mucosa-associated bacterial composition in Crohn's disease: a pilot study. International journal of colorectal disease 2016 Mar . Schäffler Holger, Kaschitzki Annika, Alberts Christian, Bodammer Peggy, Bannert Karen, Köller Thomas, Warnke Philipp, Kreikemeyer Bernd, Lamprecht Geo |
| Genetic basis of TNF-a antagonist associated psoriasis in inflammatory bowel diseases: a genotype-phenotype analysis. Alimentary pharmacology & therapeutics 2016 Mar 43 (6): 697-704. Vedak P, Kroshinsky D, St John J, Xavier R J, Yajnik V, Ananthakrishnan A |
| Association of ulcerative colitis with TNF-related apoptosis inducing ligand (TRAIL) gene polymorphisms and plasma soluble TRAIL levels in Chinese Han population. European review for medical and pharmacological sciences 2015 19 (3): 467-76. Hu D, Xia S-L, Shao X-X, Yu L-Q, Lin X-X, Guo M, Lin X-Q, Jiang |
| Associations between functional polymorphisms in the NF?B signaling pathway and response to anti-TNF treatment in Danish patients with inflammatory bowel disease. The pharmacogenomics journal 2014 Dec 14 (6): 526-34. Bank S, Andersen P S, Burisch J, Pedersen N, Roug S, Galsgaard J, Turino S Y, Brodersen J B, Rashid S, Rasmussen B K, Avlund S, Olesen T B, Hoffmann H J, Thomsen M K, Thomsen V Ø, Frydenberg M, Nexø B A, Sode J, Vogel U, Andersen |
| Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-?-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment. Gut 2014 Apr 63 (4): 567-77. Tillack Cornelia, Ehmann Laura Maximiliane, Friedrich Matthias, Laubender Rüdiger P, Papay Pavol, Vogelsang Harald, Stallhofer Johannes, Beigel Florian, Bedynek Andrea, Wetzke Martin, Maier Harald, Koburger Maria, Wagner Johanna, Glas Jürgen, Diegelmann Julia, Koglin Sarah, Dombrowski Yvonne, Schauber Jürgen, Wollenberg Andreas, Brand Steph |
| Influence of polymorphisms and TNF and IL1ß serum concentration on the infliximab response in Crohn's disease and ulcerative colitis. European journal of clinical pharmacology 2013 Mar 69 (3): 431-8. Lacruz-Guzmán Diana, Torres-Moreno Daniel, Pedrero Francisco, Romero-Cara Patricia, García-Tercero Iván, Trujillo-Santos Javier, Conesa-Zamora Pab |
| Genetics of inflammatory bowel disease in Asia: systematic review and meta-analysis. Inflammatory bowel diseases 2012 Jun 18 (6): 1164-76. Ng Siew C, Tsoi Kelvin K F, Kamm Michael A, Xia Bing, Wu Justin, Chan Francis K L, Sung Joseph J |
| Role of tumor necrosis factor-alpha (C-863A) polymorphism in pathogenesis of inflammatory bowel disease in Northern India. Journal of gastrointestinal cancer 2012 Jun 43 (2): 196-204. Ahirwar Dinesh K, Kesarwani Pravin, Singh Ranjana, Ghoshal Uday Chand, Mittal Rama De |
| [TNF alfa polymorphism and course of ulcerative colitis]. Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 2009 May 26 (155): 444-5. Ja?ocha ?ukasz, Wojtu? Stanis?aw, Dyrla Przemys?aw, Gil Jerzy, Korsak Jolanta, Rzeszotarska Agnieszka, Fiedorowicz E |
| Tumor necrosis factor receptor superfamily, member 1B haplotypes increase or decrease the risk of inflammatory bowel diseases in a New Zealand caucasian population. Gastroenterology research and practice 2009 2009 591704. Ferguson Lynnette R, Han Dug Yeo, Huebner Claudia, Petermann Ivonne, Barclay Murray L, Gearry Richard B, McCulloch Alan, Demmers Pieter |
| Single nucleotide polymorphism in the tumor necrosis factor-alpha gene affects inflammatory bowel diseases risk. World journal of gastroenterology : WJG 2008 Aug 14 (29): 4652-61. Ferguson Lynnette R, Huebner Claudia, Petermann Ivonne, Gearry Richard B, Barclay Murray L, Demmers Pieter, McCulloch Alan, Han Dug Y |
| Polymorphisms in the selenoprotein S gene: lack of association with autoimmune inflammatory diseases. BMC genomics 2008 9 329. Martínez Alfonso, Santiago Jose Luis, Varadé Jezabel, Márquez Ana, Lamas José Ramón, Mendoza Juan Luis, de la Calle Hermenegildo, Díaz-Rubio Manuel, de la Concha Emilio G, Fernández-Gutiérrez Benjamín, Urcelay Ele |
| Role of matrix metalloproteinase, tissue inhibitor of metalloproteinase and tumor necrosis factor-alpha single nucleotide gene polymorphisms in inflammatory bowel disease. World journal of gastroenterology : WJG 2007 Jun 13 (21): 2960-6. Meijer MJ, Mieremet-Ooms MA, van Hogezand RA, Lamers CB, Hommes DW, Verspaget HW |
| Lack of association of the CD14 promoter polymorphism--159C/T with Caucasian inflammatory bowel disease. Scandinavian journal of gastroenterology 2005 Feb 40 (2): 194-7. Peters Kirsten E, O'Callaghan Nathan J, Cavanaugh Juleen |
| TNF-alpha gene polymorphisms in Iranian Azari Turkish patients with inflammatory bowel diseases. Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association 0 20 (2): 108-12. Bonyadi Mortaza, Abdolmohammadi Reza, Jahanafrooz Zohreh, Somy Mohammad-Hosein, Khoshbaten Manooche |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 22, 2023
- Content source: